Screening: Cervical cancer-should we abandon cytology for screening?

Nature Reviews Clinical Oncology

Volumn 9, Issue 10, 2012, Pages 558-559

  Meijer, Chris J L M ^a   Berkhof, Johannes ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER CYTODIAGNOSIS; CANCER RISK; CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC VALUE; DNA DETERMINATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION;

CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 84867099881     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.161     Document Type: Short Survey

References (10)

1. Whitlock, E. P. et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U. S. Preventive Services Task Force. Ann. Intern. Med. 155, 687-697 (2011).
2. Arbyn, M. et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine (in press).
3. Castle, P. E. et al. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2011.38.8389.
4. Schiffman, M. et al. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol. Biomarkers Prev. 20, 1398-1409 (2011).
5. Naucler, P. et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J. Natl Cancer. Inst. 101, 88-99 (2009).
6. Rijkaart, D. C. et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int. J. Cancer 130, 602-610 (2012).
7. Castle, P. E. et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 12, 880-890 (2011).
8. Petry, K. U. et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecol. Oncol. 121, 505-509 (2011).
9. Hesselink, A. T. et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin. Cancer Res. 17, 2459-2465 (2011).
10. Saslow, D. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am. J. Clin. Pathol. 137, 516-542 (2012).